Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers

NCT01229371 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Inflexal V influenza vaccine (CSL HA Antigen) 2010
BIOLOGICAL: Inflexal V influenza vaccine (AdImmune HA antigen) 2010/2011

Sponsor

Crucell Holland BV